Key result
Preoperative HbA1c levels ≥7% in patients undergoing elective coronary artery bypass grafting increased 30-day mortality to 8.3% compared to 0% in nondiabetic controls.
Why the study?
Does preoperative HbA1c level predict short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery?
Cohort (n=180)
Does preoperative HbA1c level predict short-term morbidity and mortality outcomes following coronary artery bypass grafting surgery?
The study investigates the role of preoperative HbA1c levels in predicting short-term morbidity and mortality after CABG.
Answers are grounded in this paper and cite their sources.
May warrant enhanced monitoring in poorly controlled diabetics; leaves open whether preoperative optimization improves CABG outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Arslan et al. (2015) conducted a cohort in Coronary artery disease undergoing elective CABG (n=180). Preoperative HbA1c ≥7% vs. Preoperative HbA1c <6% (nondiabetic) was evaluated on 30-day mortality (p=0.02). Preoperative HbA1c levels ≥7% in patients undergoing elective coronary artery bypass grafting increased 30-day mortality to 8.3% compared to 0% in nondiabetic controls.
Synapse has enriched 10 related papers. Consider them for comparative context: